Ricoh 3D
Provides end-to-end additive manufacturing services, including FDA-cleared patient-specific 3D printed medical devices and on-demand production for industries like automotive and consumer goods, leveraging proprietary materials and a managed print model.
- CEO / Founder
- Gary Turner (Vice President and General Manager, Ricoh 3D for Healthcare; Managing Director, Additive Manufacturing North America at Ricoh USA)
- Team Size
- 10000+
- Stage
- Active
- Total Funding
- $25K
- Latest Round
- Grant
- Key Investors
- Greater Winston-Salem Inc.; Whitaker Park Development Authority
Technology & Products
Key Products
Offers FDA 510(k)-cleared 3D printed anatomic models for healthcare, comprehensive additive manufacturing services from prototyping to mass production, and managed on-site 3D printing solutions.
Technological Advantage
Proprietary binder jetting process for aluminum parts and unique Polypropylene materials, protected by 654 patents in 3D printing (ranking 14th globally); ISO 13485:2016 certified facilities ensure regulatory compliance for medical applications.
Differentiation
Value Proposition
Reduces lead times for medical anatomic models from weeks to days with FDA 510(k) clearance, offers a B2C-like online ordering system for seamless 3D prints, and provides dedicated technical specialists for tailored project support, enabling cost-effective on-demand production.
How They Differentiate
Offers a comprehensive managed print service with dedicated technical specialists, unlike Stratasys' focus on printer sales; uses proprietary binder jetting for aluminum at higher speeds than traditional metal AM; provides FDA-cleared point-of-care medical manufacturing, a niche not fully covered by EOS.
Market & Competition
Target Customers
Hospitals, clinics, industrial manufacturers, automotive companies, and consumer product brands seeking prototyping, mass production, or point-of-care medical device manufacturing.
Industry Verticals
Medical; Industrial; Automotive; Consumer Products; Aerospace/Defense
Competitors
Materialise, Protolabs, Stratasys
Growth & Milestones
Growth Metrics
Entering accelerated growth phase with new healthcare subsidiary; 5-year incubation period; projected 3D printed medical device market growth from $5.59B in 2025 to $24.69B by 2034
Major Milestones
Established Ricoh 3D for Healthcare LLC in 2025; Received expanded FDA 510(k) clearance for 3D anatomic modeling of soft tissue; Launched point-of-care 3D medical device manufacturing facility at Atrium Health Wake Forest Baptist; Implemented Materialise CO-AM software in April 2025 for optimized operations
Notable Customers
Atrium Health Wake Forest Baptist; The Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Trust